Literature DB >> 2394777

Effects of 13 cis-retinoic acid on growth and differentiation of human follicular carcinoma cells (UCLA R0 82 W-1) in vitro.

A J Van Herle1, M L Agatep, D N Padua, T L Totanes, D V Canlapan, H M Van Herle, G J Juillard.   

Abstract

Dedifferentiation of human thyroid tumors is frequently found in humans. The effect of retinoids (13 cis-RA) was studied on the proliferation and differentiation of a human follicular cell line in vitro (UCLA R0 82 W-1). A significant and dose-dependent reduction (P less than 0.001) in cell number and [3H] thymidine uptake was found in cells exposed to 13 cis-RA up to 10 microM. Higher concentrations of 13 cis-RA, however, led to a dose-dependent restoration of cell proliferation. Various parameters of differentiation increased under the influence of 13 cis-RA (10 microM) over nonexposed cells. The 125I uptake increased 4-fold over that in control nonexposed cells (P less than 0.05). [125I] Epidermal growth factor binding increased 5-fold, and [125I] human TSH binding increased significantly after exposure to 13 cis-RA (P less than 0.02). Deiodinase activity, however, was significantly lower in 13 cis-RA exposed cells than in control cells. The present study shows that 13 cis-RA (10 microM) drives the tumor cells toward a more normal state of proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394777     DOI: 10.1210/jcem-71-3-755

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  The management of metastatic differentiated thyroid carcinoma.

Authors:  S I Sherman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 3.  Retinoid pathway and cancer therapeutics.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  Adv Drug Deliv Rev       Date:  2010-08-03       Impact factor: 15.470

4.  Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma.

Authors:  S Mendes Coelho; R Corbo; A Buescu; D P Carvalho; M Vaisman
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

5.  Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.

Authors:  Eleonore Fröhlich; Peter Brossart; Richard Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-24       Impact factor: 9.236

Review 6.  Retinoids: novel immunomodulators and tumour-suppressive agents?

Authors:  M R Carratù; C Marasco; G Mangialardi; A Vacca
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 7.  Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.

Authors:  Ji Min Oh; Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

8.  Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.

Authors:  Naifa Lamki Busaidy; Maria E Cabanillas
Journal:  J Thyroid Res       Date:  2012-02-28

9.  13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.

Authors:  Daria Handkiewicz-Junak; Jozef Roskosz; Kornelia Hasse-Lazar; Sylwia Szpak-Ulczok; Zbigniew Puch; Aleksandra Kukulska; Tomasz Olczyk; Andrzej Piela; Ewa Paliczka-Cieslik; Barbara Jarzab
Journal:  Thyroid Res       Date:  2009-08-01

10.  Histopathological prognosis of papillary thyroid carcinoma associated with nutritional status of vitamins A and E.

Authors:  Lara Lima-Antoine; Julianna Lys de Sousa Alves Neri; Thaisa Cristina Tavares de Melo; Isabela Samária Fernandes Leite; Diego Marques da Costa Santos; Jéssica Nayara Góes de Araújo; Ana Gabriella da Costa Lemos Silva; Nathália Kelly de Araújo; Carlos C de Oliveira Ramos; Sheila Ramos de Miranda Henriques Tarrapp; Andre Ducati Luchessi; Clélia de Oliveira Lyra; Karla Danielly da Silva Ribeiro; Vivian Nogueira Silbiger
Journal:  Eur J Clin Nutr       Date:  2021-07-06       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.